Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advanced analytical methods for hemoglobin variants.

Yoshinao Wada1

  • 1Department of Molecular Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan. wada@mch.pref.osaka.jp

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|November 27, 2002
PubMed
Summary

Mass spectrometry enables rapid detection of hemoglobin variants, crucial protein mutations. This protein analysis method remains essential for identifying mutations and post-translational modifications, even with advances in DNA sequencing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approaches to diagnostic screening for congenital disorders of glycosylation and its prevalence in Japan.

Journal of human genetics·2025
Same author

The long way to diagnosis: attention disorder, alcohol addiction or congenital disorder of glycosylation? A case report.

BMC psychiatry·2025
Same author

Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan.

JIMD reports·2025
Same author

Erratum: Mass Spectrometry as a First-Line Diagnostic Aid for Congenital Disorders of Glycosylation.

Mass spectrometry (Tokyo, Japan)·2025
Same author

Mass Spectrometry as a First-Line Diagnostic Aid for Congenital Disorders of Glycosylation.

Mass spectrometry (Tokyo, Japan)·2025
Same author

Quantitative Assessment of Core Fucosylation for Congenital Disorders of Glycosylation.

Mass spectrometry (Tokyo, Japan)·2024

Area of Science:

  • Biochemistry
  • Proteomics
  • Clinical Chemistry

Background:

  • Hemoglobin variants represent common protein mutations with significant clinical relevance.
  • Traditional analytical methods like electrophoresis and chromatography have limitations in resolution and speed.
  • Hemoglobin variants serve as valuable models for advancing protein analysis techniques.

Purpose of the Study:

  • To highlight the utility of mass spectrometry in analyzing hemoglobin variants.
  • To demonstrate the effectiveness of mass spectrometry in detecting mutations and post-translational modifications.
  • To emphasize the continued importance of protein analysis in clinical settings.

Main Methods:

  • Mass spectrometry-based strategies for protein mutation analysis.

Related Experiment Videos

  • Measurement of globin molecular mass to detect mutations.
  • Peptide mass mapping/fingerprinting to identify mutated peptides.
  • Tandem mass spectrometry for precise mutation site and type determination.

    • Main Results:

    • Mass spectrometry enables rapid and sensitive detection of hemoglobin variants.
    • This approach effectively identifies variants missed by traditional methods.
    • Protein analysis via mass spectrometry is crucial for detecting post-translational modifications.

    Conclusions:

    • Mass spectrometry offers a powerful strategy for analyzing hemoglobin variants and other protein mutations.
    • Protein analysis remains indispensable for comprehensive clinical diagnostics, complementing DNA-based methods.
    • Understanding post-translational modifications is vital for accurate interpretation of protein function and disease association.